vs
Progyny, Inc.（PGNY）与威立（WLY）财务数据对比。点击上方公司名可切换其他公司
威立的季度营收约是Progyny, Inc.的1.3倍（$421.8M vs $318.4M），威立净利率更高（10.6% vs 3.9%，领先6.7%），Progyny, Inc.同比增速更快（6.7% vs -1.1%），Progyny, Inc.自由现金流更多（$48.6M vs $-4.6M），过去两年Progyny, Inc.的营收复合增速更高（7.0% vs -4.3%）
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
约翰威立国际出版公司是美国跨国出版企业，1807年成立，专注于学术出版与教学资料发行。业务覆盖纸质和电子形式的图书、期刊、百科全书，同时面向本科生、研究生及继续教育群体提供线上产品与服务、培训材料和教育资源，在全球学术与教育出版领域拥有深厚积累。
PGNY vs WLY — 直观对比
营收规模更大
WLY
是对方的1.3倍
$318.4M
营收增速更快
PGNY
高出7.8%
-1.1%
净利率更高
WLY
高出6.7%
3.9%
自由现金流更多
PGNY
多$53.2M
$-4.6M
两年增速更快
PGNY
近两年复合增速
-4.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $318.4M | $421.8M |
| 净利润 | $12.5M | $44.9M |
| 毛利率 | 24.1% | 75.2% |
| 营业利润率 | 4.8% | 17.3% |
| 净利率 | 3.9% | 10.6% |
| 营收同比 | 6.7% | -1.1% |
| 净利润同比 | 18.5% | 11.0% |
| 每股收益（稀释后） | $0.14 | $0.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PGNYWLY
| Q4 25 | $318.4M | $421.8M | ||
| Q3 25 | $313.3M | $396.8M | ||
| Q2 25 | $332.9M | $442.6M | ||
| Q1 25 | $324.0M | $404.6M | ||
| Q4 24 | $298.4M | $426.6M | ||
| Q3 24 | $286.6M | $403.8M | ||
| Q2 24 | $304.1M | $468.5M | ||
| Q1 24 | $278.1M | $460.7M |
净利润PGNYWLY
| Q4 25 | $12.5M | $44.9M | ||
| Q3 25 | $13.9M | $11.7M | ||
| Q2 25 | $17.1M | $68.1M | ||
| Q1 25 | $15.1M | $-23.0M | ||
| Q4 24 | $10.5M | $40.5M | ||
| Q3 24 | $10.4M | $-1.4M | ||
| Q2 24 | $16.5M | $25.3M | ||
| Q1 24 | $16.9M | $-113.9M |
毛利率PGNYWLY
| Q4 25 | 24.1% | 75.2% | ||
| Q3 25 | 23.2% | 72.5% | ||
| Q2 25 | 23.7% | 74.9% | ||
| Q1 25 | 23.4% | 74.2% | ||
| Q4 24 | 21.3% | 74.9% | ||
| Q3 24 | 20.7% | 73.0% | ||
| Q2 24 | 22.5% | 73.7% | ||
| Q1 24 | 22.4% | 68.8% |
营业利润率PGNYWLY
| Q4 25 | 4.8% | 17.3% | ||
| Q3 25 | 6.9% | 7.8% | ||
| Q2 25 | 7.3% | 17.3% | ||
| Q1 25 | 7.5% | 12.8% | ||
| Q4 24 | 5.3% | 15.0% | ||
| Q3 24 | 4.3% | 7.2% | ||
| Q2 24 | 6.8% | 14.7% | ||
| Q1 24 | 6.7% | -10.1% |
净利率PGNYWLY
| Q4 25 | 3.9% | 10.6% | ||
| Q3 25 | 4.4% | 2.9% | ||
| Q2 25 | 5.1% | 15.4% | ||
| Q1 25 | 4.6% | -5.7% | ||
| Q4 24 | 3.5% | 9.5% | ||
| Q3 24 | 3.6% | -0.4% | ||
| Q2 24 | 5.4% | 5.4% | ||
| Q1 24 | 6.1% | -24.7% |
每股收益（稀释后）PGNYWLY
| Q4 25 | $0.14 | $0.84 | ||
| Q3 25 | $0.15 | $0.22 | ||
| Q2 25 | $0.19 | $1.25 | ||
| Q1 25 | $0.17 | $-0.43 | ||
| Q4 24 | $0.12 | $0.74 | ||
| Q3 24 | $0.11 | $-0.03 | ||
| Q2 24 | $0.17 | $0.45 | ||
| Q1 24 | $0.17 | $-2.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.2M | $67.4M |
| 总债务越低越好 | — | $871.7M |
| 股东权益账面价值 | $516.0M | $740.2M |
| 总资产 | $742.4M | $2.5B |
| 负债/权益比越低杠杆越低 | — | 1.18× |
8季度趋势，按日历期对齐
现金及短期投资PGNYWLY
| Q4 25 | $112.2M | $67.4M | ||
| Q3 25 | $134.0M | $81.8M | ||
| Q2 25 | $132.5M | $85.9M | ||
| Q1 25 | $109.2M | $104.5M | ||
| Q4 24 | $162.3M | $75.5M | ||
| Q3 24 | $91.5M | $82.5M | ||
| Q2 24 | $95.0M | $83.2M | ||
| Q1 24 | $115.0M | $93.1M |
总债务PGNYWLY
| Q4 25 | — | $871.7M | ||
| Q3 25 | — | $828.3M | ||
| Q2 25 | — | $799.4M | ||
| Q1 25 | — | $887.2M | ||
| Q4 24 | — | $961.0M | ||
| Q3 24 | — | $918.6M | ||
| Q2 24 | — | $774.6M | ||
| Q1 24 | — | $906.8M |
股东权益PGNYWLY
| Q4 25 | $516.0M | $740.2M | ||
| Q3 25 | $560.0M | $733.1M | ||
| Q2 25 | $515.0M | $752.2M | ||
| Q1 25 | $467.2M | $685.2M | ||
| Q4 24 | $422.1M | $755.3M | ||
| Q3 24 | $434.9M | $713.7M | ||
| Q2 24 | $456.2M | $739.7M | ||
| Q1 24 | $571.6M | $748.3M |
总资产PGNYWLY
| Q4 25 | $742.4M | $2.5B | ||
| Q3 25 | $795.2M | $2.5B | ||
| Q2 25 | $761.0M | $2.7B | ||
| Q1 25 | $730.3M | $2.6B | ||
| Q4 24 | $607.1M | $2.6B | ||
| Q3 24 | $660.0M | $2.7B | ||
| Q2 24 | $698.6M | $2.7B | ||
| Q1 24 | $794.3M | $2.7B |
负债/权益比PGNYWLY
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.13× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 1.29× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.2M | $8.5M |
| 自由现金流经营现金流 - 资本支出 | $48.6M | $-4.6M |
| 自由现金流率自由现金流/营收 | 15.3% | -1.1% |
| 资本支出强度资本支出/营收 | 1.8% | 3.1% |
| 现金转化率经营现金流/净利润 | 4.34× | 0.19× |
| 过去12个月自由现金流最近4个季度 | $191.8M | $162.5M |
8季度趋势，按日历期对齐
经营现金流PGNYWLY
| Q4 25 | $54.2M | $8.5M | ||
| Q3 25 | $50.7M | $-85.0M | ||
| Q2 25 | $55.5M | $150.3M | ||
| Q1 25 | $49.8M | $146.2M | ||
| Q4 24 | $52.2M | $-5.3M | ||
| Q3 24 | $44.5M | $-88.7M | ||
| Q2 24 | $56.7M | $183.3M | ||
| Q1 24 | $25.7M | $107.8M |
自由现金流PGNYWLY
| Q4 25 | $48.6M | $-4.6M | ||
| Q3 25 | $46.0M | $-97.0M | ||
| Q2 25 | $50.2M | $131.2M | ||
| Q1 25 | $47.0M | $132.9M | ||
| Q4 24 | $50.3M | $-19.8M | ||
| Q3 24 | $42.7M | $-103.2M | ||
| Q2 24 | $55.8M | $164.5M | ||
| Q1 24 | $24.9M | $90.9M |
自由现金流率PGNYWLY
| Q4 25 | 15.3% | -1.1% | ||
| Q3 25 | 14.7% | -24.4% | ||
| Q2 25 | 15.1% | 29.6% | ||
| Q1 25 | 14.5% | 32.9% | ||
| Q4 24 | 16.8% | -4.6% | ||
| Q3 24 | 14.9% | -25.6% | ||
| Q2 24 | 18.4% | 35.1% | ||
| Q1 24 | 8.9% | 19.7% |
资本支出强度PGNYWLY
| Q4 25 | 1.8% | 3.1% | ||
| Q3 25 | 1.5% | 3.0% | ||
| Q2 25 | 1.6% | 4.3% | ||
| Q1 25 | 0.9% | 3.3% | ||
| Q4 24 | 0.6% | 3.4% | ||
| Q3 24 | 0.6% | 3.6% | ||
| Q2 24 | 0.3% | 4.0% | ||
| Q1 24 | 0.3% | 3.7% |
现金转化率PGNYWLY
| Q4 25 | 4.34× | 0.19× | ||
| Q3 25 | 3.65× | -7.27× | ||
| Q2 25 | 3.24× | 2.21× | ||
| Q1 25 | 3.31× | — | ||
| Q4 24 | 4.95× | -0.13× | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 3.44× | 7.25× | ||
| Q1 24 | 1.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
WLY
| Research Publishing | $241.4M | 57% |
| Academic Products | $87.0M | 21% |
| Professional Products | $56.2M | 13% |
| Research Solutions | $37.1M | 9% |
